KE Kimball Electronics, Inc.
Kimball Electronics, Inc. provides electronics, assemblies, and contract manufacturing organization solutions. The company offers electronics manufacturing services, including engineering and supply chain support to customers in the automotive, medical, and industrial end markets, as well as contract manufacturing organization solutions comprising the production of medical disposables and drug delivery services, such as precision molded plastics, cold chain management, and drug integration. It also engages in the production and testing of printed circuit board assemblies; assembly of medical, automotive, and industrial products; and clean room assembly, cold chain, and product sterilization management activities. In addition, the company offers design services and support, supply chain services and support, rapid prototyping and new product introduction support, product design and process validation and qualification, industrialization and automation of manufacturing processes, reliability testing, aftermarket services, and product life cycle management services. It operates in the United States, China, Mexico, Poland, Romania, Thailand, and internationally. Kimball Electronics, Inc. was founded in 1961 and is headquartered in Jasper, Indiana.…
Industry Peers
Electrical Equipment & PartsKey Statistics
About Kimball Electronics (NASDAQ: KE)
›
Kimball Electronics (NASDAQ: KE) is listed on Nasdaq, where its shares trade in USD. It belongs to the Electrical Equipment & Parts industry, part of the Industrials sector, and reports about 5,600 employees.
The shares were at 17.92 USD on 20 November 2026, down 34.2% over 52 weeks. Its 52-week range is 17.65 USD to 32.00 USD: the price is 44.0% below the high and 1.5% above the low.
At a market capitalisation of 429.94M USD, it trades at 21.3 times trailing earnings and 10.2 times forward earnings. The median trailing P/E of its 19 largest Electrical Equipment & Parts peers is 24.7, a discount of 14% for KE.
Kimball Electronics reports return on equity of 4.8%, an operating margin of 3.6% and revenue up 6.9% year over year.
Its debt exceeds its cash by 179.25M USD, a debt-to-equity ratio of 0.20. Its Piotroski F-score is 7 out of 9, a strong reading of its financial health. 3 analysts cover the stock, with an average rating of Buy; their mean price target of 34.67 USD is 93.5% above the current price. The next earnings report is expected on 3 February 2027.